Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1987 | 03-1987 | 12-1986 | 09-1986 | 06-1986 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,469 | 13,661 | 13,098 | 13,323 | 2,422 |
| Receivables | 91 | 63 | 37 | 30 | 5 |
| Inventories | 49 | 40 | 32 | 27 | 22 |
| Other current assets | 375 | 166 | 117 | 80 | 302 |
| TOTAL | $13,984 | $13,930 | $13,284 | $13,460 | $2,750 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 22 | 24 | 24 | 25 | 26 |
| TOTAL | $22 | $24 | $24 | $25 | $26 |
| Total Assets | $14,608 | $14,517 | $13,806 | $13,967 | $3,210 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 107 | 135 | 92 | 56 | 134 |
| Accrued Expenses | 493 | 319 | 223 | 328 | 459 |
| Other current liabilities | 1,076 | 849 | 160 | 0 | 0 |
| TOTAL | $1,676 | $1,303 | $475 | $510 | $593 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,676 | $1,303 | $475 | $510 | $593 |
| Shareholders' Equity | |||||
| Common Shares | 8 | 8 | 8 | 8 | 3 |
| Retained earnings | -3,723 | -3,426 | -3,308 | -3,181 | -2,898 |
| Other shareholders' equity | 2,466 | 2,466 | 2,467 | 2,465 | 5,120 |
| TOTAL | $12,931 | $13,214 | $13,331 | $13,457 | $2,617 |
| Total Liabilities And Equity | $14,607 | $14,517 | $13,806 | $13,967 | $3,210 |